UNSPSC 51292902: Clomipramine

This classification denotes a tricyclic antidepressant with the molecular formula C19H23ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NUV44L116D, chemically known as 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-5h-dibenz(b,f)azepine but generally known as clomipramine, which bears US NIH Compound Identifier 2801. European Medicines Agency schedules Clomipramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06725MIG.

UNSPSC 51292902 Clomipramine is a Commodity code that designates a specific pharmaceutical product, but the recent state and local solicitation activity under this code does not reflect pharmaceutical procurement. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, a mismatch with the code's nominal scope of clomipramine (a tricyclic antidepressant). The code shows little relevant recent activity aligned with its pharmaceutical definition. State and local governments tagging procurement under this code appear to be using it incorrectly or the taxonomy mapping has drifted from actual buying patterns in the jurisdictions sourcing these products.

The single recent opportunity identified is Seminole County, Florida, which issued the naloxone and deactivation-systems IFB with a response deadline of July 26, 2023, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement mandated E-Verify compliance, drug-free workplace certification, and standard insurance coverage (workers' compensation, commercial general liability, professional liability). The contract structure includes a two-year initial term with a one-year renewal option and a three-month probationary period. No explicit set-aside or preference designations were noted. Given the misalignment between the code name and the actual solicitation, business development professionals should verify UNSPSC coding with issuing bodies before pursuing opportunities tagged under 51292902, or consider whether this code is actively used for state and local pharmaceutical or medical-supply procurement in other jurisdictions.